CJC-1295 with DAC (5 mg)

CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone releasing hormone (GHRH) analogue that has been extensively studied for its extended half-life properties. The DAC modification allows for sustained activity, making it a popular choice in growth hormone research.
Key research areas include:

• Sustained growth hormone elevation over extended periods

• Enhanced GH pulsatility and IGF-1 response

• Body composition and metabolic pathway studies

• Recovery and regeneration research protocols

• Synergistic effects when paired with GHRP compounds

 
Supplied at 5 mg potency with 99%+ purity, backed by third-party HPLC analysis and full Certificate of Analysis.
For laboratory and research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.